LPL Financial
CGTX icon

LPL Financial’s Cognition Therapeutics CGTX Stock Holding History

LPL Financial’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,500
Closed -$15.5K – 6009
2025
Q4 		$15.5K Sell
11,500
-3,773
-25% -$6.12K ﹤0.01% 5828
2025
Q3 		$20.6K Buy
+15,273
New +$20.8K ﹤0.01% 5739

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

LPL Financial's CGTX Position: Q1 2026 in Review

LPL Financial sold out of Cognition Therapeutics (CGTX) in Q1 2026, closing a stake of 11,500 shares — an estimated $15.5K sold.

LPL Financial first reported a position in CGTX in Q3 2025 and held it in 2 quarters. The position peaked at $20.6K in Q3 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • LPL Financial reported no remaining Cognition Therapeutics position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 11,500 Cognition Therapeutics shares in Q1 2026, an estimated $15.5K.
  • LPL Financial first reported a position in Cognition Therapeutics in Q3 2025 and held it in 2 quarters.
  • LPL Financial's Cognition Therapeutics position peaked at $20.6K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.